Waters Corporation Receives CE Mark for Innovative Blood Culture System to Improve Infection Diagnostics

Revolutionizing Diagnostics: BD BACTEC FXI Culture System

Waters Corporation has achieved a significant milestone in clinical microbiology with the recent CE marking of its next-generation BD BACTEC™ FXI Culture System. This innovative fully automated blood culture system is designed to enhance the speed, consistency, and precision of bloodstream infection diagnostics, making it a critical addition to modern microbiology laboratories across Europe.

Understanding the Importance of Timely Diagnostics

Timely identification of bloodstream infections is crucial in medical settings. According to clinical studies, the BD BACTEC FXI System boasts a mean time to detection that is approximately three hours faster compared to its predecessor, the BD BACTEC™ FX System. This translates into a 15% reduction in time, which is pivotal for initiating targeted antimicrobial therapy in patients suspected of having bloodstream infections or sepsis. Given that sepsis-related deaths accounted for a staggering 31.5% of global fatalities in 2021, the importance of rapid diagnostics cannot be understated. Studies further reveal that every hour of delay in administering antibiotics correlates with increased mortality risks.

Dr. Rafael Cantón, head of Clinical Microbiology at University Hospital Ramón y Cajal in Madrid, emphasizes the importance of advanced diagnostic tools in improving clinical decision-making. He asserts that the BD BACTEC FXI System reflects a mature approach to blood culture diagnostics with a strong focus on reliability and usability, which enhances laboratory workflow.

Innovations at the Heart of the BD BACTEC FXI System

A standout feature of the BD BACTEC FXI System is its unique ability to automate the gravimetric measurement of individual blood culture vial volumes. This capability is unprecedented in blood culture platforms and addresses a prevalent issue in clinical practices where approximately 85% of blood culture vials are improperly filled. By objectively verifying the blood volume in each vial, this system significantly reduces the chances of pre-analytical variability, thereby bolstering diagnostic accuracy and ensuring adherence to preferred collection practices.

Equipped with fully automated workflows, the BD BACTEC FXI System manages vial loading, unloading, incubation, and detection alerts, offering a state-of-the-art solution for high-throughput microbiology laboratories. Its capacity to load up to 60 samples simultaneously not only minimizes manual workload but also maximizes walk-away time, allowing laboratory professionals to concentrate on more critical tasks.

Tailored Solutions for Diverse Laboratory Needs

Adaptability is another advantage offered by the BD BACTEC FXI System, which comes in modules that can accommodate either 480 or 960 vials. This flexibility facilitates the efficient management of testing volumes and tailored solutions for laboratories of various sizes, enhancing operational efficiency and outcome quality.

According to Jianqing Bennett, Senior Vice President at Waters Advanced Diagnostics, this system marks a vital leap forward in automated microbiology. It combines speed, scalability, and automation to support laboratory modernization, addressing the worldwide demand for rapid and reliable infectious disease testing.

To ensure the successful launch and widespread adoption of the BD BACTEC FXI System, Waters Corporation has fortified its manufacturing supply chain by diversifying sourcing, enhancing supplier relationships, and reinforcing operational resilience while maintaining a strong commitment to quality.

Demonstration and Future Availability

The BD BACTEC FXI System is set to be showcased at the ESCMID Global 2026 conference in Munich, featuring live demonstrations that highlight its capabilities. Currently, the system is available in European and Japanese markets, with plans for regulatory approvals in additional key regions worldwide.

In summary, the BD BACTEC FXI Culture System represents a substantial advancement in the realm of automated microbiology diagnostics. By integrating advanced technology into blood culture diagnosis, Waters Corporation is not only enhancing patient care through improved diagnostics but is also making strides in combating antibiotic resistance and supporting a more effective healthcare ecosystem.